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1. Introduction 
The suggested importance of the natural poly- 
amines putrescine, spermidine and spermine in the 
macromolecular synthesis and proliferation of animal 
cells .[ 1,2] has generally been confirmed by results 
obtained with inhibitors of polyamine synthesis. 
However, studies of virus production in the inhibitor- 
treated cells which could serve as a model system 
to explore the cellular function(s) of polyamlnes, 
have revealed conflicting results. A decrease of the 
formation of vaccinia virus and human cytomegalo- 
virus (HCMV) has been observed [3-51 in cells 
treated with methylglyoxal bis(guanylhydrazone), 
an inhibitor of S-adenosylrnethionine decarboxylase 
(EC 4.1 .l SO), whereas this drug did not affect [4,6] 
the production of herpes implex viruses (HSV-1 
and HSV-2). Similarly, D ,L-cll-methylornithine , a 
competitive inhibitor of omithlne decarboxylase 
(EC 4.1 .1.17), had no effect on the replication of 
HSV-1 and HSV-2, but decreased the production of 
HCMV [4]. However, in [7] no effect on the HCMV 
synthesis was observed in cells treated with o-methyl- 
omithine or its derivative, D,Ladifluoromethyl- 
omithine (DFMO). Further studies of this system 
seemed therefore desirable, with special attention 
being paid to the effect of the experimental set-up 
and the specificity of the action of the inhibitor. 
Here, we show that the production of two differ- 
ent types of viruses, HSV-2 and Semliki Forest virus, 
is inhibited in cells pretreated with DMFO. This 
inhibition could be abolished by exogenous poly- 
amines. 
* Address correpondence to: Professor Aarne Raina 
2. Materials and methods 
BHK2 1, a continuous cell line derived from baby 
hamster kidney, and Vero cells were grown in Eagle’s 
minimal essential medium (MEM) supplemented with 
10% fetal calf serum, penicillin (200 U/ml) and strep- 
tomycin (100 pg/ml). A prototype strain of Semliki 
Forest virus (SFV) was obtained from Dr L. Kairi~nen 
(University of Helsinki) and strain 333 of herpes 
simplex virus type 2 (HSV-2) from Dr F. Rapp 
(Pennsylvania State University, Hershey). Stock cul- 
tures of both viruses were grown in BHK21 cells, and 
infectivity, as plaque forming units (p.f.u.), was deter- 
mined in BHK2 1 cells for SFV and in Vero cells for 
HSV-2. 
D,Liu-Difhroromethylornithine was a generous gift 
from Centre de Recherche Merrell International, 
Strasbourg. Polyamines obtained from commercial 
sources were purified as in [8]. Iproniazid phosphate 
was a product of Hoffmann-La Roche. 
The experiments were started by subculturing 
BHK21 cells in plastic Petri dishes (diam. 50 mM) at a 
ratio of -1:lO (3.5 X 10’ cells/dish). The cells were 
grown in the presence of 1 mM iproniazid (an inhibi- 
tor of serum amine oxidase, see [9]) and in the pres- 
ence or absence of DFMO and 10 /.IM polyamine 
before infection with SFV (50 p.f.u./cell) or with 
HSV-2 (5 p.f.u./cell) as in [9,10]. After adsorption 
for 1 h the maintenance medium (MEM containing 
0.2% bovine serum albumin and the same additions as 
the corresponding growth medium) was added. The 
production of SFV was determined from samples of 
the medium 8 h post infection and that of HSV-2 
from cell sonicates prepared in the medium at 20 h 
post infection. Virus titers were expressed as p.f.u./pg 
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cellular DNA. DNA was determined according to 
[I l] from similarly treated but non-infected cultures. 
3. Results and discussion 
D,L+Difluoromethylornithine has been shown to 
effectively decrease the concentrations of putrescine 
and spermidine in cultured rat hepatoma and mouse 
leukemia cells, and also in tumor cells in vivo, fol- 
lowed by inhibition of cell replication [ 12,131. In 
agreement with these observations, treatment of 
BHK21 cells for 24 h with 2 mM DFMO markedly 
diminished cellular putrescine and spermidine, 
whereas the concentration of spermine did not 
change or was even increased (not shown). There was 
little influence on the accumulation of DNA and 
RNA during the first 24 h, but after 2day treatment 
the net accumulation of nucleic acids was almost 
completely prevented. A similar delay was observed 
in the inhibition of protein synthesis as measured by 
the incorporation of [14C]leucine. The inhibition of 
macromolecular synthesis and cell proliferation by 
DFMO was reversed by 10 PM spermidine added to 
the growth medium. 
The delay in the appearance of the inhibition of 
virus production in DFMO-treated cells was even 
longer than that observed in cellular nucleic acid syn- 
thesis. As seen in table 1, the yield of HSV-2 and SFV 
was even increased during the first 2 days, but was 
clearly decreased after treatment for 72 h. In later 
experiments a pretreatment of 72 h was used. 
As is seen in table 2,10 PM spermidine added at 
various times during the pretreatment with DFMO 
Table 1 
HSV-2 and SFV production in BHK21 cells pretreated with 
5 mM DFMO 
Time of pre- Virus production (%) 
treatment (h) 
HSV-2 SFV 
0a 120 185 
24 137 192 
48 128 123 
72 42 33 
a DFMO added after virus adsorption 
The number of viruses in control cultures (2.73 X lo3 p.f.u. 
for HSV-2 and 1.3 X 10’ p.f.u./rg cellular DNA for SFV) 
was taken as 100%. All values are means of 2 parallel dishes 
Table 2 
Effect of spermidine on HSV-2 and SFV production in 
DFMO-treated cells 
Time of sperm- Virus production 
idine addition 
before infec- HSV-2 SFV 
tion (h) 
Control DFMO Control DFMO 
(%) (%) 
No spermidine 4.1 x 10” 19 3.5 x lo6 11 
24 3.8 x 10’ 53 4.0 x lo6 113 
48 5.1 x lo5 49 3.9 x lo6 149 
72 4.7 x 10’ 96 3.1 X lo6 123 
BHK21 cells were grown for 72 h in the absence (control) or 
presence of 2 mM DFMO before infection. Spermidine 
(10 NM) was added at indicated times to both control and 
DFMO-treated cultures 
abolished the inhibition of virus production. In the 
case of HSV-2 the reversal appeared fairly slowly, but 
was complete in 24 h in the case of SFV. As shown in 
table 3, the addition of 10 PM spermidine at 12 h 
before infection partly reversed the inhibition. 
Next the specificity of the reversal by polyamines 
was studied. As may be seen from table 4, putrescine 
and spermidine added 24 h before infection completely 
reversed the inhibition of SFV production. Cadaver- 
ine was somewhat less effective and no effect was 
found with 13diaminopropane or spermine. Because 
the latter may only slowly penetrate the cell mem- 
brane, additional studies were carried out with sperm- 
Table 3 
Reversal by spermidine of the inhibition of SFV production 
in DFMO-treated cells 
Time of spermidine Virus production 
addition before 
infection (h) p.f .u./fig DNA % 
No spermidine 0.78 X lo6 4 
No spermidinea 1.17 x lo6 7 
2 2.34 X lo6 13 
4 1.50 x lo6 9 
8 2.92 x lo6 17 
12 1.08 x 10’ 62 
24 1.95 x 10’ 112 
a Spermidine added after adsorption 
BHK21 cells were grown for 72 h in the absence or presence 
of 2 mM DFMO. Iproniazid (1 mM) was added at 48 h to alI 
cultures. Virus production in the control culture (1.74 X 10’ 
p.f.u./Ccg DNA) was taken as 100% 
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Table 4 
Effect of various polyamines on SFV production in DFMO- 
treated cells 
Additions Virus production 
p.f.u./pg DNA % 
Control 
DFMO 
DFMO + 1,3diaminopropane 
DFMO + putrescine 
DFMO + cadaverine 
DFMO + spermidine 
DFMO + spermine 
7.0 x lo6 100 
6.3 x 10’ 9 
7.4 x lo* 11 
1.0 x 10’ 143 
5.6 x lo6 80 
7.1 x lo6 101 
4.8 x 10” 7 
BHK21 cells were grown for 72 h in the presence of 2 mM 
DFMO. Iproniazid (1 mM) and polyamines (10 PM) were 
added 24 h before infection 
me. The results (not shown) demonstrated that 
spermine effectively increased virus yield in DFMO- 
treated cells when added 48-72 h before infection. 
From our results il appears that the effect of 
inhibitors of polyamine synthesis on virus production 
is dependent on several factors, e.g., the specificity of 
the inhibitor, the duration of pretreatment, the cell 
density at the start of pretreatment. These factors 
seem to explain at least partly the discrepancy in the 
earlier results (see section 1). It has been shown that 
some inhibitors, e.g., 1,3-diaminopropane and meth- 
ylglyoxal bis(guanylhydrazone), have acute effects 
unrelated to polyamine deficiency [9,14]. DFMO, 
being a potent and specific inhibitor of polyamine 
synthesis and showing a remarkably low toxicity in 
tissue cultures and whole animals [ 131, is clearly 
superior to these drugs. A short pretreatment ime 
possibly explains why o-methylornithine and methyl- 
glyoxal bis(guanylhydrazone) did not affect the rep- 
lication of herpes simplex viruses in some earlier 
studies [4,6]. In [7] DFMO did not inhibit the pro- 
duction of HCMV. In that study confluent or nearly 
confluent cell cultures were used, which may delay 
the appearance of polyamine deficiency. ’ 
Our data strongly suggests that polyamines or 
polyaminedependent factor(s) are needed for HSV-2 
and SFV replication. This view is supported by the 
observation that the inhibition of virus production by 
DFMO was reversed by exogenous polyamines. The 
inhibition of vaccinia virus replication by methyl- 
glyoxal bis(guanylhydrazone) was also reversed by 
spermidine in [3], but in this case the interpretation 
is complicated by the finding that the inhibitor and 
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the polyamines compete for a common uptake sys- 
tem [ 151. The mechanisms by which polyamine 
deficiency interferes with virus production are not 
known. Virus replication consists of several steps 
which may be sensitive to polyamine depletion. As 
pointed out [ 161, the sensitive step(s) may be virus 
specific and/or include a malfunction of cellular 
macromolecule synthesis. e.g., at the ribosomal level. 
We are currently investigating the target site(s) of 
polyamine depletion in the virus replication cycle and 
in the host macromolecular synthesis. 
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